Document:

Exhibit
      10.20

     

    NEITHER
      THIS SECURITY NOR THE SECURITY INTO WHICH THIS SECURITY IS EXERCISABLE HAVE
      BEEN
      REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES
      COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER
      THE SECURITIES ACT OF 1933, AS AMENDED, AND, ACCORDINGLY, MAY NOT BE OFFERED
      OR
      SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES
      ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT
      TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH
      APPLICABLE STATE SECURITIES LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL
      TO
      THE TRANSFEROR TO SUCH EFFECT, THE SUBSTANCE OF WHICH SHALL BE REASONABLY
      ACCEPTABLE TO THE COMPANY.

     

    Warrant
      No. W-July07-02

    

    Void
      after 5:00 p.m., Eastern Standard Time on July 20, 2012

    

    UNIT
      PURCHASE WARRANT

     

    DRTATTOFF,
      LLC,
      a
      California limited liability company (the “Company”),
      hereby certifies that, for value received,
      Ian
      Kirby, located at 560 N. Kings Road #3, West Hollywood, CA 90048   (the
      “Warrant
      Holder”)
      is the
      owner of the number of unit purchase warrants (“Warrants”)
      which
      entitles the holder thereof to purchase, at any time during the period
      commencing on the Commencement Date (as defined herein) and ending on the
      Expiration Date (as defined herein), Five Hundred and Fifty six (556) fully
      paid
      and non-assessable units of Membership Interest (as defined in the Company's
      Operating Agreement dated as of July 5, 2005, as amended to date (the "Operating
      Agreement")) in the Company (each a "Unit"), each representing a Percentage
      Interest (as defined in the Operating Agreement) equal to 0.0009890% on a
      fully-diluted basis as of the date hereof at a purchase price equal to the
      Exercise Price (as defined below) in lawful money of the United States of
      America in cash, subject to adjustment as hereinafter provided. Each Unit shall
      include the right to receive allocations of Net Profits and Net Losses and
      distributions from the Company. For the avoidance of doubt, the securities
      which
      the Warrant Holder is permitted to purchase hereunder (whether prior to or
      after
      adjustment of the Warrant Units or securities to which this Warrant applies)
      shall be equal to .5499% of the total equity securities of the Company on a
      fully-diluted basis as of the date hereof.

     

    1. WARRANT;
      EXERCISE PRICE.

     

    1.1 This
      Warrant is issued pursuant to a Subscription Agreement dated as of the date
      hereof, by and among the Company and the Warrant Holder (the “Subscription
      Agreement”).

    
      
        
          
          

        

        
          
          

          
            

          

        

        
          
          

        

      

    

     

    1.2 Each
      Warrant shall entitle the Warrant Holder to purchase one Unit (individually,
      a
“Warrant
      Unit”
      severally, the “Warrant
      Units”).
      Each
      Warrant Unit shall provide the holder of such Unit with a capital account
      balance equal to the exercise price paid for such Warrant Unit. 

     

    1.3 The
      purchase price payable upon exercise of each Warrant (the “Exercise
      Price”)
      shall
      be (i) in the event that the Company completes a merger of the Company with
      and
      into Lifesciences Opportunities, Inc. (the "Merger"), (A) the actual exercise
      price for a Warrant issued in the Company's next equity financing (whether
      completed before, after or contemporaneously with the Merger), subject to any
      adjustments pursuant to Section 8 to make such Warrant equivalent to the
      Warrants hereunder, (B) if no Warrant is offered in the next equity financing
      (whether completed before, after or contemporaneously with the Merger), then
      in
      such event only, the purchase price per security which the Warrant Holder is
      entitled to purchase upon the exercise of this Warrant will be equal to the
      actual purchase price paid for each such security in the next equity financing,
      or (C) if no such financing is completed by the Company after the Merger, then
      the purchase price per security which the Warrant Holder is entitled to purchase
      shall be equal to (1) the Exercise Price identified in (ii) below (as adjusted
      by the provisions of Article 8), divided by (2) the number of shares or other
      securities issuable or exchangeable for each Warrant through the Merger) or
      (ii)
      if the Warrant is exercised prior to the Merger, then the exercise price shall
      be $92.72 per Unit, subject to any adjustments pursuant to Section 8.
      Notwithstanding the foregoing, the Exercise Price and number of Warrant Units
      purchasable pursuant to each Warrant are subject to adjustment as provided
      in
      Section 8. 

     

    2. EXERCISE
      OF WARRANT; EXPIRATION DATE.
      

     

    2.1 This
      Warrant is exercisable at any time and from time to time commencing the date
      hereof (“Commencement
      Date”)
      and
      ending at 5:00 p.m., Eastern Time on June 15, 2012 (the “Expiration
      Date”),
      in
      whole or from time to time in part, at the option of the Warrant Holder, upon
      surrender of this Warrant to the Company together with a duly completed Notice
      of Exercise in the form attached hereto and payment of an amount equal to the
      then applicable Exercise Price multiplied by the number of Warrant Units then
      being purchased upon such exercise. 

     

    2.2 Each
      exercise of this Warrant shall be deemed to have been effected immediately
      prior
      to the close of business on the day on which this Warrant shall have been
      surrendered to the Company as provided in Section 2.1. At such time, the person
      or persons in whose name or names any certificates for Warrant Units shall
      be
      issuable upon such exercise as provided in Section 2.3 below shall be deemed
      to
      have become the holder or holders of record of the Warrant Units represented
      by
      such certificates.

     

    2.3 Within
      three business days after the exercise of the purchase right represented by
      this
      Warrant, the Company at its expense will use its reasonable best efforts to
      cause to be issued in the name of, and delivered to, the Warrant Holder, or,
      subject to the terms and conditions hereof, to such other individual or entity
      as such Warrant Holder (upon payment by such Warrant Holder of any applicable
      transfer taxes) may direct: 

    
      
        
        

      

      
        2

        
          

        

      

      
        
        

      

    

     

    (a) a
      certificate or certificates for the number of full Warrant Units to which such
      Warrant Holder shall be entitled upon such exercise , and 

     

    (b) in
      case
      such exercise is in part only, a new Warrant or Warrants (dated the date hereof)
      of like tenor, stating on the face or faces thereof the number of Units
      currently stated on the face of this Warrant minus the number of such Units
      purchased by the Warrant Holder upon such exercise as provided in Section 2.2
      (in each case prior to any adjustments made thereto pursuant to the provisions
      of this Warrant).

     

    3. REGISTRATION
      AND TRANSFER ON COMPANY BOOKS.
      

     

    3.1 The
      Company (or an agent of the Company) will maintain a register containing the
      names and addresses of the Warrant Holders. Any Warrant Holder may change its,
      his or her address as shown on the warrant register by written notice to the
      Company requesting such change. 

     

    3.2 The
      Company shall register upon its books any transfer of a Warrant upon surrender
      of same as provided in Section 5. 

     

    4. RESERVATION
      OF UNITS.
      The
      Company will at all times reserve and keep available, solely for issuance and
      delivery upon the exercise of this Warrant, such Warrant Units and other stock,
      securities and property, as from time to time shall be issuable upon the
      exercise of this Warrant. As
      long
      as the Warrant shall be outstanding, the Company shall use its commercially
      reasonable efforts to cause all Warrant Units issuable upon exercise of the
      Warrants to be listed (subject to official notice of issuance) on each Exchange
      (or, if applicable on Nasdaq, NASD OTC Bulletin Board or Pink Sheets, LLC or
      any
      successor electronic quotation service and trading market) on which the
      Company's Membership Interests are then listed and/or quoted, if
      any. 

     

    5. EXCHANGE,
      TRANSFER, ASSIGNMENT OR LOSS OR MUTILATION OF WARRANTS.
      This
      Warrant is exchangeable, without expense, at the option of the Warrant Holder,
      upon presentation and surrender hereof to the Company for other warrants of
      different denominations entitling the holder thereof to purchase in the
      aggregate the same number of Units purchasable hereunder. Subject to the terms
      of Sections 6 and 7, upon surrender of this Warrant to the Company at its
      principal office or at the office of its transfer agent, if any, with the
      Assignment Form annexed hereto duly executed and funds sufficient to pay any
      transfer tax, the Company shall, without charge, execute and deliver a new
      Warrant in the name of the assignee named in such instrument of assignment
      and
      this Warrant shall be promptly canceled. Subject to the terms of Sections 6
      and
      7, this Warrant may be divided or combined with other warrants which carry
      the
      same rights upon presentation hereof at the principal office of the Company
      together with a written notice specifying the names and denominations in which
      new Warrants are to be issued and signed by the Warrant Holder hereof. The
      term
“Warrant” as used herein includes any Warrants into which this Warrant may be
      divided or exchanged. Upon receipt by the Company of reasonable evidence of
      the
      ownership of and the loss, theft, destruction or mutilation of this Warrant
      and,
      in the case of loss, theft or destruction, of indemnity reasonably satisfactory
      to the Company, or, in the case of mutilation, upon surrender and cancellation
      of the mutilated Warrant, the Company shall execute and deliver in lieu thereof
      a new Warrant of like tenor and date representing an equal number of Warrants.
      

    
      
        
        

      

      
        3

        
          

        

      

      
        
        

      

    

     

    6. LIMITATION
      ON EXERCISE AND SALES.
      

     

    (a)
       Each
      holder of this Warrant acknowledges that this Warrant and the Warrant Units
      have
      not been registered under the Securities Act, as of the date of issuance hereof.
      This Warrant only may be transferred in compliance with this Section 6 and
      Section 7. The Company shall be under no obligation to issue the Units covered
      by such exercise unless and until the Warrant Holder shall have executed the
      form of exercise annexed hereto that states that at the time of such exercise
      that it is then an “accredited investor” within the meaning of Rule 501 of
      Regulation D, is acquiring such Units for its own account, and will not transfer
      the Warrant Units unless pursuant to an effective and current registration
      statement under the Securities Act or an exemption from the registration
      requirements of the Securities Act and any other applicable restrictions, in
      which event the Warrant Holder shall be bound by the provisions of a legend
      or
      legends to such effect that shall be endorsed upon the certificate(s)
      representing the Warrant Units issued pursuant to such exercise. In such event,
      the Warrant Units issued upon exercise hereof shall be imprinted with a legend
      in substantially the form provided in Section 7(b). 

    

    (b) Warrant
      Holder represents and warrants that it is acquiring this Warrant for its own
      account, for purposes of investment, and not with a view to, or for sale in
      connection with, any distribution thereof within the meaning of the Securities
      Act and the rules and regulations promulgated thereunder. Warrant Holder
      represents, warrants and agrees that it will not sell, exercise, transfer or
      otherwise dispose of this Warrant (or any interest therein) or any of the Units
      purchasable upon exercise hereof, except pursuant to (i) an effective
      registration statement under the Securities Act and applicable state securities
      laws or (ii) an opinion of counsel, satisfactory to Company, that an exemption
      from registration under the Securities Act and such laws is available. Warrant
      Holder further acknowledges and agrees that Company is not required, legally
      or
      contractually, so to register or qualify the Warrant or such Units or to take
      any action to make such an exemption available. Warrant Holder understands
      that
      Company will be relying upon the truth and accuracy of the representations
      and
      warranties contained in this Section 6 in issuing this Warrant and such Units
      without first registering the issuance thereof under the Securities Act or
      qualifying or registering the issuance thereof under any state securities laws
      that may be applicable.

    

    (c) Warrant
      Holder acknowledges that (i) there is not now, and there may not be in the
      future, any public market for the Warrant, (ii) although there currently is
      not
      a public trading market for the Units, there can be no assurance that any such
      market will be created and sustained, and (iii) there can be no assurance that
      Warrant Holder will be able to liquidate its investment in Company. Warrant
      Holder represents and warrants that it is familiar with and understands the
      terms and conditions of Rule 144 promulgated under the Securities
      Act.

    

    (d)
       Warrant
      Holder represents and warrants to Company that (i) it has such knowledge and
      experience in financial and business matters as is necessary to enable it to
      evaluate the merits and risks of any investments in Company and is not utilizing
      any other person to be a purchaser representative in connection with evaluation
      of such merits and risks; and (ii) it has no need for liquidity in an investment
      in Company and is able to bear the risk of that investment for an indefinite
      period and to afford a complete loss thereof.

    
      
        
        

      

      
        4

        
          

        

      

      
        
        

      

    

     

    (e) Warrant
      Holder represents and warrants that it has had access to, and has been furnished
      with, all of the information it has requested from Company and has had an
      opportunity to review the books and records of Company and to discuss with
      management and members of the board of directors of Company the business and
      financial affairs of Company.

    

    (f)
       Warrant
      Holder agrees that at the time of each exercise of this Warrant, unless the
      issuance of Units issuable thereupon is pursuant to an effective registration
      statement under the Securities Act and under applicable state blue sky laws,
      Warrant Holder will provide Company with a letter embodying the representations
      and warranties set forth in subsections (b) through (e), in form and substance
      reasonably satisfactory to Company, and agrees that the certificate(s)
      representing any shares issued to it upon any exercise of this Warrant may
      bear
      such restrictive legend as Company may deem necessary to reflect the restricted
      status of such shares under the Securities Act unless Company shall have
      received from Warrant Holder an opinion of counsel to Warrant Holder, reasonably
      satisfactory in form and substance to Company and its counsel, that such
      restrictive legend is not required.

     

    7. TRANSFER
      RESTRICTIONS.

     

    (a) If,
      at the
time
      of
      the surrender of this Warrant in connection with any transfer of this Warrant,
      the transfer of this Warrant shall not be registered pursuant to an effective
      registration
      statement under the Securities Act
      and
under
      applicable state securities or blue sky laws, the Company may require, as a
      condition of allowing such transfer (i) that the Warrant Holder or transferee
      of
      this Warrant, as the case may be, furnish to the Company a written opinion
      of
      counsel (which opinion shall be in form, substance and scope customary for
      opinions of counsel in comparable transactions and reasonably satisfactory
      to
      counsel for the Company) to the effect that such transfer may be made
      without
      registration under the
      Securities Act and under applicable state securities or blue sky laws, (ii)
      that
      the holder or transferee execute and deliver to the Company an investment letter
      in form and substance acceptable to the Company, (iii) that transferee agree
      in
      writing with the Company to be bound by the terms and conditions of this Warrant
      applicable to the Warrant Holder and (iv) that the transferee be an “accredited
      investor” as defined in Regulation D promulgated under the Securities
      Act.

     

    (b) The
      Units
      issuable on the exercise of the Warrant shall bear the following
      legend:

     

    THESE
      SECURITIES HAVE NOT BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION,
      OR THE SECURITIES COMMISSION OF ANY STATE, IN RELIANCE UPON AN EXEMPTION FROM
      REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES
      ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN
      EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN
      AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION
      REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE
      SECURITIES LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL TO THE TRANSFEROR
      TO
      SUCH EFFECT, THE SUBSTANCE OF WHICH SHALL BE REASONABLY ACCEPTABLE TO THE
      COMPANY.

     

    
      
        
        

      

      
        5

        
          

        

      

      
        
        

      

    

     

    (c) The
      Holder acknowledges that the Warrant Units acquired upon the exercise of this
      Warrant, if not registered, will have restrictions upon resale imposed by state
      and federal securities laws.

     

    8. ADJUSTMENT
      OF EXERCISE PRICE AND NUMBER OF UNITS DELIVERABLE.
      The
      Exercise Price and the number of Warrant Units purchasable pursuant to each
      Warrant shall be subject to adjustment from time to time as hereinafter set
      forth in this Section 8: 

     

    (a) In
      case,
      prior to the expiration of this Warrant by exercise or by its terms, the Company
      shall issue any additional units of Membership Interest as a dividend or
      subdivide the number of outstanding Units into a greater number of units of
      Membership Interest, then in either of such cases, the then applicable Exercise
      Price per Warrant Unit purchasable pursuant to this Warrant in effect at the
      time of such action shall be proportionately reduced and the number of Warrant
      Units at that time purchasable pursuant to this Warrant shall be proportionately
      increased; and conversely, in the event the Company shall reduce the number
      of
      outstanding units of Membership Interest by combining such units into a smaller
      number of units of Membership Interest then, in such case, the then applicable
      Exercise Price per Warrant Unit purchasable pursuant to this Warrant in effect
      at the time of such action shall be proportionately increased and the number
      of
      Warrant Units at that time purchasable pursuant to this Warrant shall be
      proportionately decreased. If the Company shall, at any time during the life
      of
      this Warrant, declare a dividend payable in cash on its Membership Interest
      and
      shall at substantially the same time offer to its stockholders a right to
      purchase new units of Membership Interest from the proceeds of such dividend
      or
      for an amount substantially equal to the dividend, all units of Membership
      Interest so issued shall, for the purpose of this Warrant, be deemed to have
      been issued as a dividend. Any dividend paid or distributed upon the Membership
      Interests in units of any other class of securities convertible into units
      of
      Membership Interest shall be treated as a dividend paid in units of Membership
      Interest to the extent that units of Membership Interest are issuable upon
      conversion thereof.

     

    (b) In
      case,
      prior to the expiration of this Warrant by exercise or by its terms, the Company
      shall be recapitalized by reclassifying its outstanding units of Membership
      Interest, (or the Company or a successor corporation shall consolidate or merge
      with or convey all or substantially all of its or of any successor corporation’s
      property and assets to any other corporation or corporations (any such other
      corporations being included within the meaning of the term “successor
      corporation” hereinbefore used in the event of any consolidation or merger of
      any such other corporation with, or the sale of all or substantially all of
      the
      property of any such other corporation to, another corporation or corporations),
      then, as a condition of such recapitalization, consolidation, merger or
      conveyance, lawful and adequate provision shall be made whereby the holder
      of
      this Warrant shall thereafter have the right to purchase, upon the basis and
      on
      the terms and conditions specified in this Warrant, in lieu of the Warrant
      Units
      theretofore purchasable upon the exercise of this Warrant, such shares of stock,
      securities or assets, as may be issued or payable with respect to, or in
      exchange for, the number of Warrant Units theretofore purchasable upon the
      exercise of this Warrant had such recapitalization, consolidation, merger,
      or
      conveyance not taken place, and the exercise price for which shall have been
      appropriately adjusted to reflect the number of securities which the Warrant
      Holder is entitled to purchase in exchange for such Warrant; and in any such
      event, the rights of the Warrant Holder to any adjustment in the number of
      Warrant Units purchasable upon the exercise of this Warrant, as herein provided,
      shall continue and be preserved in respect of any stock which the Warrant Holder
      becomes entitled to purchase.

    
      
        
        

      

      
        6

        
          

        

      

      
        
        

      

    

     

    (c) In
      case
      the Company at any time while this Warrant shall remain unexpired and
      unexercised shall sell all or substantially all of its property or dissolve,
      liquidate, or wind up its affairs, lawful provision shall be made as part of
      the
      terms of any such sale, dissolution, liquidation or winding up, so that the
      holder of this Warrant may thereafter receive upon exercise hereof in lieu
      of
      each Warrant Unit that it would have been entitled to receive, the same kind
      and
      amount of any securities or assets as may be issuable, distributable or payable
      upon any such sale, dissolution, liquidation or winding up with respect to
      each
      Unit of the Company, provided, however, that in any case of any such sale or
      of
      dissolution, liquidation or winding up, the right to exercise this Warrant
      shall
      terminate on a date fixed by the Company; such date so fixed to be not earlier
      than 5:00 p.m., Eastern Time, on the forty-fifth day next succeeding the date
      on
      which notice of such termination of the right to exercise this Warrant has
      been
      given by mail to the registered holder of this Warrant at its address as it
      appears on the books of the Company.

     

    9. VOLUNTARY
      ADJUSTMENT BY THE COMPANY.
      The
      Company may, at its option, at any time during the term of the Warrants, reduce
      the then current Exercise Price to any amount deemed appropriate by the Managing
      Members of the Company and/or extend the date of the expiration of the Warrants.
      

     

    10. RIGHTS
      OF THE HOLDER.
      The
      Warrant Holder shall not, by virtue hereof, be entitled to any rights of a
      member in the Company, either at law or equity, and the rights of the Warrant
      Holder are limited to those expressed in this Warrant and are not enforceable
      against the Company except to the extent set forth herein. This Warrant does
      not
      entitle the Holder to any voting rights or other rights as a member of the
      Company prior to the Exercise Date and then only with respect to the Warrant
      Units to be issued with respect thereto. 

     

    11. NOTICES
      OF RECORD DATE.
      In
      case: 

     

    (a) the
      Company shall take a record of the holders of its Units (or other stock or
      securities at the time deliverable upon the exercise of this Warrant) for the
      purpose of entitling or enabling them to receive any dividend or other
      distribution, or to receive any right to subscribe for or purchase any
      Membership Interests or any other securities, or to receive any other right,
      or

     

    (b) of
      any
      capital reorganization of the Company, any reclassification of the equity
      capital of the Company, any consolidation or merger of the Company with or
      into
      a corporation or other entity (other than a consolidation or merger in which
      the
      Company is the surviving entity), or any transfer of all or substantially all
      of
      the assets of the Company, or 

     

    
      
        
        

      

      
        7

        
          

        

      

      
        
        

      

    

     

    (c) of
      the
      voluntary or involuntary dissolution, liquidation or winding-up of the Company,
      

     

    then,
      and
      in each such case, the Company will mail or cause to be mailed to the Warrant
      Holder a notice specifying, as the case may be, (i) the date on which a record
      is to be taken for the purpose of such dividend, distribution or right, and
      stating the amount and character of such dividend, distribution or right, or
      (ii) the effective date on which such reorganization, reclassification,
      consolidation, merger, transfer, dissolution, liquidation or winding-up is
      to
      take place, and the time, if any is to be fixed, as of which the holders of
      record of Units (or such other stock or securities at the time deliverable
      upon
      the exercise of this Warrant) shall be entitled to exchange their Units (or
      such
      other stock or securities) for securities or other property deliverable upon
      such reorganization, reclassification, consolidation, merger, transfer,
      dissolution, liquidation or winding-up. Such notice shall be mailed at least
      ten
      days prior to the record date or effective date for the event specified in
      such
      notice, provided that the failure to mail such notice shall not affect the
      legality or validity of any such action. 

     

    12. SUCCESSORS.
      The
      rights and obligations of the parties to this Warrant will inure to the benefit
      of and be binding upon the parties hereto and their respective heirs,
      successors, assigns, pledgees, transferees and purchasers. 

     

    13. CHANGE
      OR WAIVER.
      Any
      term of this Warrant may be changed or waived only by an instrument in writing
      signed by the party against whom enforcement of the change or waiver is sought.
      

     

    14. HEADINGS.
      The
      headings in this Warrant are for purposes of reference only and shall not limit
      or otherwise affect the meaning of any provision of this Warrant. Wherever
      possible, each provision of this Warrant shall be interpreted in such manner
      as
      to be effective and valid under applicable law, but if any provision of this
      Warrant shall be prohibited by or invalid under applicable law, such provision
      shall be ineffective to the extent of such prohibition or invalidity, without
      invalidating the remainder of such provisions or the remaining provisions of
      this Warrant.

     

    15. Governing
      Law.
      This
      Warrrant shall be governed by and construed in accordance with the laws of
      the
      State of California. Any action or litigation brought by either party against
      the other concerning the transactions contemplated by this Warrant shall be
      brought only in the state courts or in the federal courts located in the state
      of California prevailing party shall be entitled to recover from the other
      party
      its reasonable attorney’s fees and costs.

     

    16. MAILING
      OF NOTICES, ETC.
      All
      notices and other communications required or permitted hereunder shall be in
      writing and shall be deemed to have been duly given one (1) business day after
      delivery to an overnight carrier with instructions to deliver to the
      applicable

     

    
      
         

      

      
        8

        
          

        

      

      
         

      

    

     

    address
      set forth below, or, if sent by facsimile, upon receipt of a confirmation of
      delivery: 

     

    
      	
              Registered
                Holder:

            	
              To
                his or her last known address as indicated on the Company’s books and
                records.

            
	 	 
	
              The
                Company:

            	
              DrTattoff,
                LLC

            
	 	
              8500
                Wilshire Blvd,

            
	 	
              Beverly
                Hills CA 90211

            
	 	
              Attention:
                James Morel, President

            
	 	
              Fax:
                310-659-4159

            

    

    

    [Signature
      Page Follows]

    

      
        
          
          

        

        
          9

          
            

          

        

        
          
          

        

      

     

    IN
      WITNESS WHEREOF, the Company has caused this Warrant to be signed by its duly
      authorized officer as of July 24, 2007

     

    
      	
              DRTATTOFF,
                LLC

            
	 	 
	
              By:

            	
              /s/
                James Morel

            
	
              Name:
                

            	
              James
                Morel

            
	
              Title:
                

            	
              CEO

            

    

     

    
      
        
        

      

      
        10

        
          

        

      

      
        
        

      

    

    Notice
      of Exercise

    To
      Be
      Executed by the Warrant Holder

    In
      Order
      to Exercise Warrants

    

    TO:
      Dr.
      Tattoff, LLC

    

    The
      undersigned hereby: (1) irrevocably subscribes for and offers to purchase
      _______ Units (“Units”),
      of
      DrTattoff, LLC, pursuant to Warrant No. ___ heretofore issued to
      ___________________ on July 20, 2007 and (2) encloses a cash payment of
      $__________ representing the aggregate exercise price for such Unitss.

    

    The
      undersigned hereby represents and warrants to the Company that it is an
“Accredited Investor” within the meaning of Rule 501 of Regulation D promulgated
      under the Securities Act of 1933, as amended (the “Securities
      Act”),
      and
      is acquiring these securities for its own account and not with a view to, or
      for
      sale in connection with, any distribution thereof, nor with any present
      intention of distributing or selling the same. The undersigned further
      represents that it does not have any contract, agreement, understanding or
      arrangement with any person to sell, transfer or grant the Units issuable under
      this Warrant. The undersigned understands that the shares it will be receiving
      are “restricted securities” under Federal securities laws inasmuch as they are
      being acquired from DrTattoff, LLC, in transactions not including any public
      offering and that under such laws, such shares may only be sold pursuant to
      an
      effective and current registration statement under the Securities Act or an
      exemption from the registration requirements of the Securities Act and any
      other
      applicable restrictions, in which event a legend or legends will be placed
      upon
      the certificate(s) representing the Units issuable under this Warrant denoting
      such restrictions. The undersigned understands and acknowledges that the Company
      will rely on the accuracy of these representations and warranties in issuing
      the
      securities underlying the Warrant.

    

    [warrant
      notice of exercise signature page to follow]

    
      
        
        

      

      
        11

        
          

        

      

      
        
        

      

    

    Exhibit
      10.20

    

    [warrant
      notice of exercise signature page]

    

    
      	
              Date:

            	 

    

    

    
      	
              Warrant
                Holder Name:

            	 

    

     

    
      	
              Taxpayer
                Identification Number:

            	 

    

    

    
      	
              By:
                

            	 
              
	 	 
	
              Printed
                Name:

            	 
              
	 	 
	
              Title:

            	 
	 	 
	
              Address:

            	 

    

    

    Note:
      The
      above signature should correspond exactly with the name on the face of this
      Warrant or with the name of assignee appearing in assignment form below.

    

    AND,
      if
      said number of shares shall be less than the total number of shares purchasable
      under the Warrant, a new Warrant is to be issued in the name of said undersigned
      for the balance remaining of the shares purchasable thereunder less any fraction
      of a share paid in cash and delivered to the address stated
      above.

    
      
        
        

      

      
        12

        
          

        

      

      
        
        

      

    

    

    ASSIGNMENT
      FORM

    To
      be
      executed by the Warrant Holder

    In
      order
      to Assign Warrants

    

    FOR
      VALUE
      RECEIVED,____________________________________ hereby sell, assigns and transfer
      unto

     

    PLEASE
      INSERT SOCIAL SECURITY OR OTHER IDENTIFYING NUMBER

     

    
      
        	 

      

       

      
        

      

       

    

    
      

    

     

    
      
 (Please
      print or type name and address)

     

    ______________________
      of the Warrants represented by this Warrant, and hereby irrevocably constitutes
      and appoints ________________________ Attorney to transfer this Warrant on
      the
      books of the Company, with full power of substitution in the
      premises.

     

    
      
        
          	
                  Dated:

                	 
	 	 
	 	 	 	
                  (Signature
                    of Registered Holder)

                

        

      

    

    

    In
      addition to executing this Assignment Form, the Warrant Holder and the
      transferee must comply with the other requirements for transfer set forth in
      Sections 6 and 7 of the Warrant.

     

    CERTIFICATION
      OF STATUS OF TRANSFEREE

    TO
      BE EXECUTED BY THE TRANSFEREE OF THIS WARRANT

    

    The
      undersigned transferee hereby certifies to the registered holder of this Warrant
      and to DR. TATTOFF, LLC that the transferee is an “accredited investor” within
      the meaning of Rule 501 of Regulation D promulgated under the Securities Act
      of
      1933, as amended.

     

    
      
        
          
            	
                    Dated:

                  	 
	 	 
	 	 	 	
                    (Signature
                      of
                      Transferee)

                  

          

        

      

    

     

    
      
        
        

      

      
        13Exhibit
      10.21

    

    Placement
      Agent Agreement

    

    June
      25,
      2007        

    

    DrTattoff,
      LLC

    8500
      Wilshire Blvd – Street
      Level
      Suite 105

    (SW
      Corner of Wilshire at La Cienega)

    Beverly
      Hills, CA 90211

    Attention:
      James Morel

    

    Dear
      James,

    

    We
      are
      pleased that Dr. Tattoff (together with its subsidiaries and affiliates, the
      “Company”) has selected Brookshire Securities Corporation (“The Placement
      Agent”) to act as its exclusive financial advisor and placement agent to assist
      the Company in connection with a best efforts private placement (the
      "Financing") of up to $3,500,000 of the Company’s equity securities (the
      "Securities"). This letter will confirm our acceptance of such retention and
      set
      forth the terms of our engagement.

    

    1.
      Retention; Terms of Financing. (a) The Company hereby retains Brookshire
      Securities Corp. (The Placement Agent) as its exclusive financial advisor and
      placement agent in connection with the proposed Financing and The Placement
      Agent accepts such retention on the terms and conditions set forth in this
      Agreement. As currently contemplated, the Financing shall consist of the sale
      of
      up to $3,500,000 of Securities. The actual size of the Financing, the terms
      of
      the Securities, the precise number of Securities to be offered by the Company
      and the offering price shall be subject to a variety of factors, including
      the
      capitalization and financial condition of the Company, changes in the Company's
      prospects and forecasts, market and general economic conditions and the results
      of negotiations with potential investors.

    

    (b) In
      its
      capacity as exclusive financial advisor and placement agent in connection with
      the Financing, The Placement Agent shall (i) familiarize itself with the
      business, operations, properties, financial condition, management and prospects
      of the Company; (ii) assist the Company in developing an appropriate structure
      for the Financing; (iii) introduce the Company to potential investors and
      contact potential investors on the Company’s behalf; (iv) assist the Company in
      any discussions and negotiations with potential investors; and (v) assist the
      Company in closing the Financing. Except as provided on Schedule 1(b) hereto,
      the Company will not contact or solicit potential investors with respect to
      the
      Financing or pursue any financing transaction in lieu of the Financing, and
      the
      Company shall refer all inquiries and offers received, directly or indirectly,
      with respect to the Financing or any financing transaction in lieu of the
      Financing to The Placement Agent (all such inquiries and offers, including
      all
      inquiries and offers which the Company may have received concerning an
      investment in the Company prior to the date hereof, being deemed to have been
      contacted by The Placement Agent in connection with the Financing). It is
      understood that upon termination of this Agreement, the Company shall have
      the
      right to contact or solicit potential investors with respect to the Financing
      in
      an effort to complete the sale the minimum amount, subject to the Company
      providing the Placement Agent with 50% of the compensation the Placement Agent
      is otherwise entitled to receive under Section 3(b), 3(c) and 4 of this
      Agreement on any such amount that the Company rises in this
      effort.

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

    
      

      May
        9,
        2007

      Page
        2

       

    

    (c) Closing
      Conditions. As a condition precedent to the obligations of the Placement Agent
      to close any financing, the Company shall:

    

    (i)
      furnish to the Placement Agent the opinion, dated the Closing Date, of its
      counsel, which opinion shall be reasonably acceptable to the Placement Agent
      and
      its counsel

     

    (ii)
      deliver and execute a closing certificate from the president or chief executive
      officer of the Company containing standard representations and warranties of
      the
      Company for a transaction of this nature which shall be true and correct on
      and
      as of the Closing.

     

    2.
      Information; Offering Materials. (a) In connection with The Placement Agent’s
      activities hereunder, the Company will furnish The Placement Agent and its
      counsel upon request with all relevant information regarding the business,
      operations, properties, financial condition, management and prospects of the
      Company (all such information so furnished being hereinafter referred to as
      the
“Information”), and with a private placement memorandum with respect to the
      Company and the Financing in a form acceptable to The Placement Agent (such
      memorandum, including any exhibits, amendments and supplements thereto, all
      documents incorporated by reference therein and all other documents, instruments
      and communications prepared for or otherwise used in connection with the
      Financing being hereinafter referred to as the “Offering Materials”). The
      Company shall also provide The Placement Agent with access to the Company’s
      officers, directors, employees, accountants and legal counsel. The Company
      acknowledges and agrees that The Placement Agent’s obligations under this
      Agreement are subject to the satisfactory completion by The Placement Agent
      of
      its due diligence review of the Company and the Offering
      Materials.

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

    
       

      May
        9,
        2007

      Page
        3

       

    

    (b)
      The
      Company represents and warrants to The Placement Agent that (i) all Information
      and the Offering Materials will be complete and correct in all material respects
      and will not contain any untrue statement of a material fact or omit to state
      a
      material fact necessary in order to make the statements therein not misleading
      in light of the circumstances under which such statements are or will be made,
      and (ii) any projections and other forward-looking information provided by
      it to
      The Placement Agent will have been prepared in good faith and will be based
      upon
      assumptions which, in light of the circumstances under which they are made,
      are
      reasonable. The Company recognizes and confirms that The Placement Agent: (1)
      will use and rely primarily on the Information, the Offering Materials and
      on
      information available from generally recognized public sources in performing
      the
      services contemplated by this Agreement without having independently verified
      the same; (2) is authorized as the Company's exclusive financial advisor and
      placement agent to transmit to any prospective investor a copy or copies of
      the
      Offering Materials, forms of purchase agreements and any other legal
      documentation supplied to The Placement Agent for transmission to any
      prospective investor by or on behalf of the Company or by any of the Company’s
      officers, representatives or agents, in connection with the performance of
      The
      Placement Agent’s services hereunder or any transaction contemplated hereby; (3)
      does not assume responsibility for the accuracy or completeness of the
      Information or Offering Materials and such other information; (4) will not
      make
      an appraisal of any assets of the Company; and (5) retains the right to continue
      to perform due diligence during the course of its engagement
      hereunder.

    

    3.
      Compensation. Except as set forth in Section 3(e) hereof, as consideration
      for
      The Placement Agent’s services pursuant to this Agreement, The Placement Agent
      shall be entitled to receive, and the Company agrees to pay The Placement Agent,
      the following compensation:

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

     

    
      May
        9,
        2007

      Page
        4

       

    

    (a)
      The
      Company shall pay to The Placement Agent, upon execution of this Agreement,
      an
      engagement fee of $5,000, which fee shall be non-refundable but shall be applied
      against The Placement Agent’s expenses as set forth in Section 4
      hereof.

    

    (b)
      Upon
      closing of the Financing, the Company shall pay to The Placement Agent, in
      cash,
      a fee in an amount equal to 8% of the aggregate gross proceeds raised in the
      Financing. If any portion of the proceeds raised in the Financing are not paid
      to the Company at the closing of the Financing but rather is deferred until
      a
      later date or satisfaction of a condition precedent, the placement fee relating
      to such deferred proceeds shall be paid by the Company upon receipt of the
      deferred proceeds. If the Financing is consummated by means of more than one
      closing, The Placement Agent shall be entitled to the fees provided herein
      with
      respect to each such closing.

    

    (c)
      The
      Company shall grant and deliver to The Placement Agent (or its designated
      nominees) at the closing of the Financing, for nominal consideration, warrants
      (the “Warrants”) to purchase a number of shares of the Company's Common Stock
      equal to 10% of the number of Units (and/or shares of Common Stock issuable
      upon
      exercise of securities or upon conversion or exchange of convertible or
      exchangeable securities) sold at such closing. If the Financing is consummated
      by means of more than one closing, The Placement Agent shall be entitled to
      receive additional Warrants at each additional closing. The Warrants shall
      be
      exercisable at any time during the five-year period commencing on the closing
      to
      which they relate at an exercise price equal to the exercise price paid by
      investors in the Financing or, in the case of exercisable, convertible, or
      exchangeable securities, the exercise, conversion or exchange price thereof,
      and
      shall contain provisions, including, without limitation, those pertaining to
      cashless exercise, anti-dilution protection and demand and piggyback
      registration rights, customarily contained in warrants received by The Placement
      Agent in similar transactions.

    

    (d)
      Notwithstanding any termination of this Agreement pursuant to the terms hereof
      or otherwise, if within 6 months from the effective date of termination of
      this
      Agreement, the Company enters into a definitive commitment relating to the
      Financing or any financing transaction in lieu of the Financing (or any portion
      thereof) with any investor to whom the Company was introduced by The Placement
      Agent or who was contacted by The Placement Agent, with the exception of any
      investors introduced to The Placement Agent by the Company or by any other
      selling group member, in connection with the Financing, the Company shall pay
      to
      The Placement Agent fees in accordance with the terms and provisions of Section
      3(b) and grant and deliver to The Placement Agent (or its designated nominees)
      Warrants in accordance with the terms and provisions of Section
      3(c).

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

    
       

      May
        9,
        2007

      Page
        5

       

    

    (e)
      In
      the event any financing hereunder is closed with any of the investors listed
      on
      Schedule 1(b), the compensation due the Placement Agent as set forth in Sections
      3 (b) and (c) hereof and Section 4 below shall each be reduced by 50%.

    

    (f)
      The
      Placement Agent will not be entitled to any compensation of any kind upon the
      exercise of any Warrants.

    

    4.
      Expenses. In addition to payment to The Placement Agent of the compensation
      set
      forth in Section 3 hereof, the Company shall pay the Selling Agent at each
      Closing a non-accountable expense allowance (the “Expense Allowance”) of 2.0% of
      the aggregate dollar value of Units sold at such Closing. Non-accountable
      expense allowance is for the reimbursement of The Placement Agents expenses
      including, without limitation, legal fees of the Placement Agent counsel and
      all
      travel and other of pocket expenses incurred by The Placement Agent in
      connection with this engagement. Without limiting the foregoing, it is agreed
      that all “blue sky” filing fees, printing costs, due diligence meetings,
      registration expenses and qualification expenses shall be paid directly by
      the
      Company.

    

    5.
      Certain Matters Relating to the Financing; Other Actions. (a) The parties
      acknowledge that it is their intention that the Financing shall be conducted
      so
      as to be exempt from the registration requirements of the Securities Act of
      1933
      (the "Act"). It is understood that investors in the Financing shall be
      "accredited investors" or fall within other categories sanctioned by Regulation
      D under the Act. The Company shall be responsible for ensuring that the sale
      of
      the Securities shall be exempt from the registration requirements of the Act
      and
      will otherwise comply with the applicable provisions of the Act and any
      regulations thereunder and any applicable laws and requirements of any country,
      state or other jurisdiction. Without limiting the foregoing, the Company
      represents and warrants that it has not, and agrees that it will not, directly
      or indirectly, engage in any form of general solicitation, general advertising
      or directed selling efforts. 

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

     

    
      May
        9,
        2007

      Page
        6

       

    

    (b) The
      sale
      of the Securities pursuant to the Financing shall be made pursuant to the terms
      of a purchase agreement or subscription agreement (each a “Purchase Agreement”)
      in form satisfactory to The Placement Agent. The Company represents and warrants
      that (i) the representations and warranties contained in each Purchase Agreement
      will be true and correct in all respects on the date such Purchase Agreement
      is
      entered into and as of the closing date of the sale of the Securities to which
      such Purchase Agreement relates, and (ii) The Placement Agent shall be entitled
      to rely on such representations and warranties (and on the representations
      and
      warranties contained in any of the other Offering Materials) as if they were
      made directly to The Placement Agent. The Placement Agent shall also be entitled
      to rely upon any opinions of counsel delivered to any purchaser of the
      Securities, including, without limitation, any opinions relating to the
      Registration Statement (as defined below)] 

    

    (c) Within
      45
      days after the closing of the reverse merger, the Company shall prepare and
      file, at the Company’s sole cost and expense, a registration statement with the
      Securities and Exchange Commission registering the resale of the shares of
      common stock underlying the Securities (the “Registration Statement”) and shall
      use its best efforts to cause the Registration Statement to be declared
      effective within 120 days from the closing of the Reverse Merger. The Company
      shall keep such Registration Statement effective until the earlier of (i) the
      date that all of the securities covered thereby have been sold, and (ii) two
      years from the effective date thereof, and shall comply with all of the other
      requirements with respect thereto set forth in the Purchase Agreements, all
      at
      the Company’s sole cost and expense.

    

    (d) During
      the period this Agreement remains in effect, and for a period of 1 year after
      the effective date of the Registration Statement, neither the Company nor any
      officer, director or person or entity who beneficially owns five percent or
      more
      of the common stock of the Company shall offer, issue, sell, contract to sell,
      grant any option for the sale of or otherwise dispose of any securities without
      The Placement Agent’s prior written consent, except for the Securities, the
      issuance of options or restricted stock awards under the Company’s or its
      successor’s employee stock incentive plans, and shares of common stock upon the
      exercise of any such stock options and any currently outstanding
      options.

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

     

    
      May
        9,
        2007

      Page
        7

       

    

    (e) The
      Company shall also execute and/or deliver such other instruments, documents
      and
      agreements (including, without limitation, delivery of such legal opinions
      and
      accountants’ “comfort letters” as The Placement Agent may request) and take such
      other action as The Placement Agent may reasonably request in connection with
      the provision of its services hereunder and the consummation of the Financing
      or
      an Alternative Transaction.

    

    6.
      Indemnification. The Company agrees to indemnify The Placement Agent in
      accordance with the indemnification and other provisions (the “Indemnification
      Provisions”) attached to this Agreement, which provisions are incorporated
      herein by reference and shall survive the termination or expiration of this
      Agreement. 

     

    7.
      Termination; Survival of Provisions. This Agreement will terminate upon the
      earlier of: 1.) the closing of the Financing 2.) Any time upon 30 days’ prior
      written notice by The Placement Agent or the Company to the other party or
      3.)
      60 days from the signing of the Placement Agent Agreement.

    

    8.
      In the
      event of such termination, the Company shall pay and deliver to The Placement
      Agent (i) all compensation earned through the date of such termination
      (“Termination Date”) pursuant to any provision of Section 3 hereof, and (ii) all
      compensation which may be earned by The Placement Agent after the Termination
      Date pursuant to Section 3(d) hereof, and shall reimburse The Placement Agent
      for expenses incurred by The Placement Agent up to a maximum of $25,000 in
      documented expenses in connection with its services hereunder pursuant to
      Section 4 hereof, provided, however that should the Company breach this
      Agreement, cap on documented expenses shall be increased to $75.000. All such
      fees and reimbursements due to The Placement Agent pursuant to the immediately
      preceding sentence shall be paid to The Placement Agent on or before the
      Termination Date (in the event such fees and reimbursements are earned or owed
      as of the Termination Date) or upon the closing of the Financing or Alternative
      Transaction or any applicable portion thereof (in the event such fees are due
      pursuant to the terms of Section 3(d hereof). Notwithstanding anything expressed
      or implied herein to the contrary, the terms and provisions of Sections 3(d),
      4,
      6 (including, but not limited to the Indemnification Provisions attached to
      this
      Agreement and incorporated herein by reference), 8, 9, 10, 11, 12, 13, 14 and
      15
      shall survive the termination of this Agreement.

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

    
       

      May
        9,
        2007

      Page
        8

    

     

    9.
      Notices. All notices provided hereunder shall be given in writing and either
      delivered personally or by overnight courier services or sent by certified
      mail,
      return receipt requested, if to The Placement Agent, to 4 West Las Olas Blvd.
      Suite 800 Ft. Lauderdale Florida 33308 and if to the Company, to the address,
      and to the attention of the person, set forth on the first page of this
      Agreement. Any notice delivered personally shall be deemed given upon receipt;
      any notice given by overnight courier shall be deemed given on the next business
      day after delivery to the overnight courier; and any notice given by certified
      mail shall be deemed given upon the second business day after certification
      thereof.

    

    10.
      Governing Law; Jurisdiction: Waiver of Jury Trial. This Agreement shall be
      governed by and construed in accordance with the laws of the State of Florida
      applicable to agreements made and to be fully performed therein, without regard
      to conflicts of law principles. The Company irrevocably submits to the exclusive
      jurisdiction of any court of the State of Florida or the United States District
      Court for the southern district of the State of Florida for the purpose of
      any
      suit, action or other proceeding arising out of this Agreement, or any of the
      agreements or transactions contemplated hereby, which is brought by or against
      the Company, and agrees that service of process in connection with any such
      suit, action or proceeding may be made upon the Company in accordance with
      Section 9 hereof. The parties hereby expressly waive any and all rights to
      trail
      by jury in any suit, action or proceeding arising under this
      Agreement.

    

    11.
      Amendments. This Agreement may not be modified or amended except in a writing
      duly executed by the parties hereto.

    

    12.
      Headings. The section headings in this Agreement have been inserted as a matter
      of reference and are not part of this Agreement.  

    

    13.
      Successors and Assigns. The benefits of this Agreement shall inure to the
      parties hereto, their respective successors and assigns and to the indemnified
      parties hereunder and their respective successors and assigns, and the
      obligations and liabilities assumed in this Agreement shall be binding upon
      the
      parties hereto and their respective successors and assigns. Notwithstanding
      anything contained herein to the contrary, neither The Placement Agent nor
      the
      Company shall assign any of its obligations hereunder without the prior written
      consent of the other party.

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

     

    
      May
        9,
        2007

      Page
        9

       

    

    14.
      No
      Third Party Beneficiaries. This Agreement does not create, and shall not be
      construed as creating, any right enforceable by any person or entity not a
      party
      hereto, except those entitled to the benefits of the Indemnification Provisions.
      Without limiting the foregoing, the Company acknowledges and agrees that The
      Placement Agent is not being engaged as, and shall not be deemed to be, an
      agent
      or fiduciary of the Company’s stockholders or creditors or any other person by
      virtue of this Agreement or the retention of The Placement Agent hereunder,
      all
      of which are hereby expressly waived.

    

    15.
      Waiver. Any waiver or any breach of any of the terms or conditions of this
      Agreement shall not operate as a waiver of any other breach of such terms or
      conditions or of any other term or condition, nor shall any failure to insist
      upon strict performance or to enforce any provision hereof on any one occasion
      operate as a waiver of such provision or of any other provision hereof or a
      waiver of the right to insist upon strict performance or to enforce such
      provision or any other provision on any subsequent occasion. Any waiver must
      be
      in writing.

    

    16.
      Press
      Announcements. At any time after the consummation or other public announcement
      of the Financing or any Alternative Transaction, The Placement Agent may place
      an announcement in such newspapers and publications as it may choose, stating
      that The Placement Agent has acted as exclusive financial advisor and/or
      placement agent to the Company in connection with the Financing or such
      Alternative Transaction. 

    

    17.
      Counterparts. For the convenience of the parties this Agreement may be executed
      in any number of counterparts, each of which shall be deemed to be an original
      instrument, but all of which taken together shall constitute one and the same
      agreement. Facsimile signatures shall be deemed to be original signatures for
      all purposes.

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

     

    
      May
        9,
        2007

      Page
        10

       

    

    If
      the
      foregoing correctly sets forth our agreement, please sign the enclosed copy
      of
      this Agreement in the space provided and return it to us.

    

    
      	
              Very
                truly yours,

            
	 
	
              /s/
                Peter S. Chung

            
	 
	
              By:

            	
              Peter
                S. Chung

            
	 	
              Name:
                Peter S. Chung

            
	 	
              Title:
                Managing Director

            

    

    

    Confirmed
      and Agreed to this

    _____
      day
      of _________, ____.

     

    DRTATTOFF,
      LLC

     

    
      	
              By:

            	
              /s/
                James Morel

            
	 	
              Name:
                James Morel

            
	 	
              Title:
                CEO

            

    

    

    Indemnification
      Provisions (attached)

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

    INDEMNIFICATION
      PROVISIONS

    

    DrTattoff,
      LLC (the “Company”) agrees to indemnify and hold harmless Brookshire Securities
      Corp. (“Placement Agent”) and each of the other Indemnified Parties (as
      hereinafter defined) from and against any and all losses, claims, damages,
      obligations, penalties, judgments, awards, liabilities, costs, expenses and
      disbursements, and any and all actions, suits, proceedings and investigations
      in
      respect thereof and any and all legal and other costs, expenses and
      disbursements in giving testimony or furnishing documents in response to a
      subpoena or otherwise (including, without limitation, the costs, expenses and
      disbursements, as and when incurred, of investigating, preparing, pursing or
      defending any such action, suit, proceeding or investigation (whether or not
      in
      connection with litigation in which any Indemnified Party is a party))
      (collectively, “Losses”), directly or indirectly, caused by, relating to, based
      upon, arising out of, or in connection with, The Placement Agent’s acting for
      the Company, including, without limitation, any act or omission by The Placement
      Agent in connection with its acceptance of or the performance or non-performance
      of its obligations under the Agreement between the Company and The Placement
      Agent to which these indemnification provisions are attached and form a part
      (the “Agreement”), any breach by the Company of any representation, warranty,
      covenant or agreement contained in the Agreement (or in any instrument,
      certificate, document or agreement relating thereto), or the enforcement by
      The
      Placement Agent of its rights under the Agreement or these indemnification
      provisions, except to the extent that any such Losses are found in a final
      judgment by a court of competent jurisdiction (not subject to further appeal)
      to
      have resulted primarily and directly from the gross negligence or willful
      misconduct of the Indemnified Party seeking indemnification hereunder. The
      Company also agrees that no Indemnified Party shall have any liability (whether
      direct or indirect, in contract or tort or otherwise) to the Company for or
      in
      connection with the engagement of The Placement Agent by the Company or for
      any
      other reason, except to the extent that any such liability is found in a final
      judgment by a court of competent jurisdiction (not subject to further appeal)
      to
      have resulted primarily and directly from such Indemnified Party’s gross
      negligence or willful misconduct.

    

    These
      indemnification provisions shall extend to the following persons (collectively,
      the “Indemnified Parties”): The Placement Agent, its present and former
      affiliated entities, managers, members, officers, employees, legal counsel,
      agents and controlling persons (within the meaning of the federal securities
      laws), and the officers, directors, partners, stockholders, members, managers,
      employees, legal counsel, agents and controlling persons of any of them. These
      indemnification provisions shall be in addition to any liability which the
      Company may otherwise have to any Indemnified Party.

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

    

    If
      any
      action, suit, proceeding or investigation is commenced, as to which an
      Indemnified Party proposes to demand indemnification, it shall notify the
      Company with reasonable promptness; provided,
      however,
      that
      any failure by an Indemnified Party to notify the Company shall not relieve
      the
      Company from its obligations hereunder. An Indemnified Party shall have the
      right to retain counsel of its own choice to represent it, and the fees,
      expenses and disbursements of such counsel shall be borne by the Company. Any
      such counsel shall, to the extent consistent with its professional
      responsibilities, cooperate with the Company and any counsel designated by
      the
      Company. The Company shall be liable for any settlement of any claim against
      any
      Indemnified Party made with the Company’s written consent. The Company shall
      not, without the prior written consent of The Placement Agent, settle or
      compromise any claim, or permit a default or consent to the entry of any
      judgment in respect thereof, unless such settlement, compromise or consent
      (i)
      includes, as an unconditional term thereof, the giving by the claimant to all
      of
      the Indemnified Parties of an unconditional release from all liability in
      respect of such claim, and (ii) does not contain any factual or legal admission
      by or with respect to an Indemnified Party or an adverse statement with respect
      to the character, professionalism, expertise or reputation of any Indemnified
      Party or any action or inaction of any Indemnified Party.

    

    In
      order
      to provide for just and equitable contribution, if a claim for indemnification
      pursuant to these indemnification provisions is made but it is found in a final
      judgment by a court of competent jurisdiction (not subject to further appeal)
      that such indemnification may not be enforced in such case, even though the
      express provisions hereof provide for indemnification in such case, then the
      Company shall contribute to the Losses to which any Indemnified Party may be
      subject (i) in accordance with the relative benefits received by the Company
      and
      its stockholders, subsidiaries and affiliates, on the one hand, and the
      Indemnified Party, on the other hand, and (ii) if (and only if) the allocation
      provided in clause (i) of this sentence is not permitted by applicable law,
      in
      such proportion as to reflect not only the relative benefits, but also the
      relative fault of the Company, on the one hand, and the Indemnified Party,
      on
      the other hand, in connection with the statements, acts or omissions which
      resulted in such Losses as well as any relevant equitable considerations. No
      person found liable for a fraudulent misrepresentation shall be entitled to
      contribution from any person who is not also found liable for fraudulent
      misrepresentation. The relative benefits received (or anticipated to be
      received) by the Company and it stockholders, subsidiaries and affiliates shall
      be deemed to be equal to the aggregate consideration payable or receivable
      by
      such parties in connection with the transaction or transactions to which the
      Agreement relates relative to the amount of fees actually received by The
      Placement Agent in connection with such transaction or transactions.
      Notwithstanding the foregoing, in no event shall the amount contributed by
      all
      Indemnified Parties exceed the amount of fees previously received by The
      Placement Agent pursuant to the Agreement.

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

    

    Neither
      termination nor completion of the engagement of The Placement Agent referred
      to
      above shall affect these indemnification provisions which shall remain operative
      and in full force and effect. The indemnification provisions shall be binding
      upon the Company and its successors and assigns and shall inure to the benefit
      of the Indemnified Parties and their respective successors, assigns, heirs
      and
      personal representatives.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00131-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00131-of-00352.parquet"}]]